ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL)

Historical Holders from Q4 2015 to Q4 2025

Type / Class: Equity / COM NEW
Symbol: AVXL on Nasdaq
Price per share: $3.56
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares as of 30 Sep 2025: 32,414,745
Total reported value: $288,983,896
% of total 13F portfolios: 0%
Share change: -7,451
Value change: -$271,918
Avg buy value change: +0%
Avg sell value change: -0%
Number of holders: 182
Price from insider filings: $9.58

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025, ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 182 institutional shareholders filing 13F forms. They hold 32,414,745 shares. .

Institutional Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (% of par)	Investors
2025 Q4	151,307	$544,823	+$288,447			356.08%	5
2025 Q3	32,414,745	$288,983,896	-$271,918	$9,208,020	$15,045,845	890%	182
2025 Q2	32,493,276	$301,726,227	+$10,099,072	$6,954,646	$9,590,611	922%	175
2025 Q1	31,369,737	$269,176,281	+$13,007,767	$5,259,114	$10,248,616	858%	178
2024 Q4	29,517,793	$315,846,815	+$29,159,103	$8,282,478	$9,645,648	1,074%	167
2024 Q3	26,968,911	$153,149,145	-$533,008	$4,476,976	$2,926,904	568%	143
2024 Q2	26,760,101	$112,930,774	-$18,727,572	$3,209,310	$2,843,014	422%	141
2024 Q1	30,926,232	$157,393,367	+$27,972,376	$6,610,892	$4,629,355	509%	145
2023 Q4	107,561	$1,006,613	-$128,134			931%	3
2023 Q3	24,759,938	$162,169,378	-$1,915,419	$7,652,293	$5,627,760	655%	136
2023 Q2	25,006,639	$203,407,463	-$13,951,764	$4,749,893	$4,960,304	813%	141
2023 Q1	26,821,822	$229,820,001	+$901,446	$7,989,985	$11,085,368	857%	136
2022 Q4	26,708,994	$247,353,216	+$23,129,346	$23,390,070	$9,953,558	926%	132
2022 Q3	24,328,020	$251,022,226	-$6,427,620	$19,182,000	$9,256,000	1,031.99%	137
2022 Q2	24,855,055	$248,828,941	-$1,786,812	$16,509,500	$6,634,000	1,000.86%	139
2022 Q1	24,881,145	$306,327,437	+$35,668,129	$7,750,000	$13,080,000	1,231%	128
2021 Q4	21,730,193	$376,713,229	+$23,082,130	$13,119,692	$15,011,000	1,733.93%	140
2021 Q3	20,602,940	$369,956,693	-$25,099,352	$12,974,000	$12,751,000	1,794.99%	131
2021 Q2	21,526,144	$492,157,598	+$83,641,389	$27,900,000	$26,494,000	2,286%	121
2021 Q1	17,922,177	$267,835,028	+$76,824,552	$7,300,000	$10,403,000	1,495%	97
2020 Q4	13,888,252	$74,995,896	+$6,360,567	$1,813,000	$1,292,000	540%	84
2020 Q3	12,654,648	$57,561,265	+$3,917,492	$1,385,000	$598,000	454.98%	72
2020 Q2	11,933,727	$58,779,085	+$1,913,567	$2,117,000	$313,000	492.09%	72
2020 Q1	9,230,313	$29,070,371	-$5,095,949	$1,584,000	$78,000	315.01%	61
2019 Q4	13,899,170	$36,000,820	+$1,470,418	$1,098,000	$195,000	258.99%	55
2019 Q3	13,275,120	$41,949,608	+$4,794,773	$1,116,000	$288,000	316.01%	52
2019 Q2	11,766,555	$39,648,052	+$14,871,615	$746,000	$186,000	336.95%	53
2019 Q1	7,377,419	$22,500,282	+$2,213,560	$419,000	$51,000	305.03%	50
2018 Q4	6,715,415	$10,473,190	-$2,650,297	$338,000	$38,000	155.98%	44
2018 Q3	8,213,369	$22,311,576	-$2,310,404	$875,000	$184,000	272.89%	44
2018 Q2	9,088,737	$23,812,662	-$3,161,271	$512,000	$87,000	262%	52
2018 Q1	10,279,544	$28,366,015	+$329,454	$388,000	$94,000	275.9%	53
2017 Q4	10,136,311	$32,637,077	+$291,374	$418,000	$103,000	322%	57
2017 Q3	10,032,704	$41,530,671	-$992,956	$4,221,000	$167,000	413.99%	59
2017 Q2	10,289,280	$54,731,640	+$4,827,566	$6,204,000	$347,000	531.92%	55
2017 Q1	9,371,190	$53,788,000	+$19,417,210	$6,926,000	$463,000	573.86%	53
2016 Q4	7,504,805	$29,715,887	+$11,504,655	$5,682,000	$118,000	396.01%	57
2016 Q3	4,581,849	$16,626,382	+$2,563,093	$946,000	$271,000	362.94%	50
2016 Q2	3,826,280	$23,378,725	+$10,539,974	$988,000	$531,000	611.04%	44
2016 Q1	2,161,346	$10,589,000	+$3,771,911	$286,000	$328,000	489.69%	39
2015 Q4	1,368,718	$7,623,000	+$7,619,984	$302,000	$1,160,000	556.7%	25